食品科学 ›› 2026, Vol. 47 ›› Issue (17): 179-189.doi: 10.7506/spkx1002-6630-20260121-176

• 营养卫生 • 上一篇    下一篇

乳酸片球菌与巴氏醋杆菌复合后生元解酒护肝功效评价

谢吉红,周海泳,杨美艳,蔡子文,吴燕婷,戴炼,周德伟,胡文锋,李雪玲   

  1. (1.华南农业大学食品学院,应用微生物实验室,广东?广州 510642;2.深圳市先达后生元科技有限公司,广东?深圳 518000;3.生物源生物技术(深圳)股份有限公司,广东?深圳 518118;4.广州柏芳生物科技有限公司,广东?广州 510765)
  • 出版日期:2026-09-15 发布日期:2026-09-03
  • 基金资助:
    广州市重点研发计划农业和社会发展科技专题项目(SL2022B03J01243); 横向合作项目(深圳市先达后生元生物科技有限公司)(xh20260171)

Anti-hangover and Hepatoprotective Efficacy of Composite Postbiotics from Pediococcus acidilactici and Acetobacter pasteurianus

XIE Jihong, ZHOU Haiyong, YANG Meiyan, CAI Ziwen, WU Yanting, DAI Lian, ZHOU Dewei, HU Wenfeng, LI Xueling   

  1. (1. Applied Microbiology Laboratory, College of Food Science, South China Agricultural University, Guangzhou 510642, China; 2. Shenzhen Xianda Postbiotic Technology Co., Ltd., Shenzhen 518000, China; 3. Biogenic Biotechnology (Shenzhen) Co., Ltd., Shenzhen 518118, China; 4. Guangzhou Bioform Biotechnology Co., Ltd., Guangzhou 510765, China)
  • Online:2026-09-15 Published:2026-09-03

摘要: 为开发安全有效的解酒护肝产品,本研究从25 株乳酸菌中筛选具有乙醇降解及抗氧化功能的菌株,制备乳酸片球菌-巴氏醋杆菌复合后生元,并探究其对酒精性急性肝损伤小鼠的保护作用。通过乙醇耐受实验、乙醇降解率测定及抗氧化活性(铁离子还原抗氧化能力、1,1-二苯基-2-三硝基苯肼自由基清除能力、2,2’-联氮双(3-乙基苯并噻唑啉-6-磺酸)阳离子自由基清除能力)检测,筛选出乙醇耐受性强、降解效率高且抗氧化活性优异的乳酸片球菌Lab2(Pediococcus acidilactici Lab2)。将该菌株后生元与巴氏醋杆菌AS1.41(Acetobacter pasteurianus AS1.41)后生元按体积比4∶1复配,开展小鼠急性酒精性肝损伤模型的干预实验。结果显示,复合后生元可显著降低酒精性肝损伤模型小鼠的肝脏指数,减轻肝细胞水肿与脂肪变性等病理损伤;同时能显著提高肝脏乙醇脱氢酶、乙醛脱氢酶活性,促进乙醇代谢;并通过提升超氧化物歧化酶、过氧化氢酶活性及谷胱甘肽含量,降低丙二醛水平,缓解氧化应激;此外,还可降低血清谷丙转氨酶、谷草转氨酶活性及甘油三酯、总胆固醇水平,改善肝功能与脂质代谢紊乱。综上,乳酸片球菌Lab2后生元与巴氏醋杆菌AS1.41后生元复合制剂有显著的解酒护肝功效,本研究可为新型解酒产品的开发提供理论依据。

关键词: 后生元;酒精性肝损伤;解酒护肝;乳酸片球菌;巴氏醋杆菌

Abstract: To develop safe and effective alcohol detoxification and hepatoprotective products, this study screened 25 lactic acid bacterial isolates for ethanol-degrading and antioxidant activities, prepared a composite postbiotic of Pediococcus acidilactici and Acetobacter pasteurianus, and evaluated its protective effect against acute alcoholic liver injury in mice. P. acidilactici Lab2 was selected for robust ethanol tolerance, high degradation efficiency, and excellent antioxidant activity in terms of ferric reducing antioxidant power (FRAP), 1,1-diphenyl-2-picryl-hydrazyl radical (DPPH), and 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) cation radical scavenging capacities. A mouse model of acute alcoholic liver injury was established and intervened with a 4:1 (V/V) composite postbiotic of P. acidilactici Lab2 and A. pasteurianus AS1.41. Results showed that the composite postbiotic significantly reduced liver index, alleviated hepatocellular edema and steatosis, and enhanced hepatic alcohol dehydrogenase (ADH) and acetaldehyde dehydrogenase (ALDH) activities to promote ethanol metabolism. Meanwhile, it mitigated oxidative stress by increasing superoxide dismutase (SOD) and catalase (CAT) activities, elevating glutathione (GSH) content, and decreasing malondialdehyde (MDA) levels. It also reduced serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), triglyceride (TG), and total cholesterol (TC) levels, thus improving liver function and ameliorating lipid metabolism disorders. Therefore, this composite postbiotics exhibited significant anti-hangover and hepatoprotective efficacy, which provides a theoretical basis for the development of novel anti-hangover products.

Key words: postbiotics; alcoholic liver injury; anti-hangover and hepatoprotective; Pediococcus acidilactici; Acetobacter pasteurianus

中图分类号: